Skip to content
Dr. Antonio Calles 馃珌馃毉路 @Tony_Calles 路 X路路 1 day agoScore45

#LCSM

Body

馃К @LeXiuning giving a comprehensive discussion of ctDNA dynamics and adaptive intensification regimen in patients with EGFRmut lung cancer.
Bottom line: combination regimens are default in first-line. #ESMO26 #LCSM

158 views 路 4 likes 路 2 reposts 路 0 replies

Source: Dr. Antonio Calles 馃珌馃毉 路 x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org